Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH)

Area of Science:

• Pulmonary Medicine
• Pathology
• Oncology

Background:

• Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a pre-invasive proliferation of pulmonary neuroendocrine (PNE) cells.
• It is often associated with carcinoid tumorlets, obliterative bronchiolitis, and fibrotic lung changes.
• Diagnostic criteria for DIPNECH have varied since its recognition in 1992.

Purpose of the Study:

• To propose standardized pathologic diagnostic criteria for DIPNECH on lung resection specimens.
• To describe the clinical and pathological features of DIPNECH patients.
• To evaluate the association of DIPNECH with other pulmonary conditions and its prognosis.

Main Methods:

• Retrospective analysis of lung resection specimens.
• Proposed criteria: multifocal PNE cell hyperplasia (≥5 PNE cells in ≥3 small airways) and ≥3 carcinoid tumorlets.
• Review of clinical data, including synchronous tumors, obliterative bronchiolitis, and treatment outcomes.

Main Results:

• Proposed criteria applied to diagnose DIPNECH.
• At diagnosis, 53% of patients had synchronous carcinoid tumors and 24% had obliterative bronchiolitis.
• Most patients (74%) had stable disease; only 26% experienced deterioration.
• No increased incidence of high-grade neuroendocrine neoplasms was observed.
• Evidence suggests octreotide or other treatments do not improve prognosis.

Conclusions:

• Standardized criteria for DIPNECH diagnosis on lung resection specimens have been proposed.
• DIPNECH is often associated with carcinoid tumorlets and obliterative bronchiolitis.
• The condition typically follows an indolent course, and current treatments lack proven efficacy.